# US Point of Care Technology Market

> US Point of Care Technology Market Research Report By Product Type (Blood Glucose Monitoring Devices, Diagnostic Imaging Devices, Cardiac Monitoring Devices, Infectious Disease Testing Devices), By End User (Hospitals, Clinics, Home Care Settings, Ambulatory Surgical Centers), By Technology (Microfluidics, Lateral Flow Technology, Biosensors, Molecular Diagnostics) and By Application (Diabetes Management, Infectious Diseases, Cardiology, Oncology) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.63%
- **2024:** $ 3,674.16 Million
- **2025:** $ 3,917.76 Million
- **2035:** $ 7,445.76 Million
- **Key Players:** Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), Becton Dickinson and Company (US), Danaher Corporation (US), Cepheid (US), Ortho Clinical Diagnostics (US), Hologic Inc. (US)

**Report ID:** MRFR/MED/13955-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-point-of-care-technology-market-15482

---

## Market Summary

## **US Point of Care Technology Market Overview**

As per MRFR analysis, the US Point of Care Technology Market Size was estimated at 8.98 (USD Billion) in 2023. The US Point of Care Technology Market Industry is expected to grow from 10 (USD Billion) in 2024 to 22 (USD Billion) by 2035. The US Point of Care Technology Market CAGR (growth rate) is expected to be around 7.431% during the forecast period (2025 - 2035).

### **Key US Point of Care Technology Market Trends Highlighted**

The US Point of Care Technology Market is experiencing significant growth driven by the increasing demand for rapid diagnostic tests, particularly in light of recent health crises that emphasize the need for immediate results. The push for home healthcare solutions and telemedicine has accelerated the adoption of point of care devices, allowing patients to receive testing and monitoring in their home environments rather than at distant healthcare facilities. This shift is further supported by the efforts of national health organizations and the government, which advocate for improved accessibility to healthcare services.

Opportunities in the US market include innovations in mobile health technology and integration with electronic health records. The synchronization of point of care devices with patient health information systems is likely to enhance clinical efficiency and patient outcomes. Furthermore, there is a growing focus on preventive care, which strengthens the demand for point of care tests that can be conducted in diverse settings, including pharmacies and community health centers.

Recent trends indicate an increasing prevalence of chronic diseases in the US population, such as diabetes and cardiovascular conditions, leading to a heightened interest in continuous monitoring technologies. The aging population also fuels the need for point of care solutions that facilitate easier management of health conditions, bridging the gap between patient care and medical intervention. In addition, regulatory changes are paving the way for quicker approvals of new point of care diagnostics, allowing for rapid uptake of innovative technologies in the market.

As a result, stakeholders in the US Point of Care Technology Market are now well-positioned to capitalize on these evolving trends and drivers.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Point of Care Technology Market Drivers**

### **Increasing Incidence of Chronic Diseases**

The rise in the number of individuals suffering from chronic diseases such as diabetes and cardiovascular conditions is a significant driver behind the US Point of Care Technology Market industry. According to the Centers for Disease Control and Prevention (CDC), about 6 in 10 adults in the United States have a chronic disease, with more than 40% having two or more. This creates a growing demand for convenient and efficient point-of-care technologies that facilitate early diagnosis and management of these conditions.

As healthcare providers can utilize these technologies to monitor patients more effectively, organizations like Abbott Laboratories and Roche Diagnostics are actively investing in R&D to enhance point-of-care testing capabilities. The continuous improvements in device accuracy and the development of innovative testing methodologies further boost this market.

### **Technological Advancements in Medical Devices**

Technological innovations are playing a crucial role in expanding the US Point of Care Technology Market industry. Rapid advancements in diagnostic tools, such as portable ultrasound, handheld devices, and connected medical technologies, are revolutionizing patient care. A report from the Food and Drug Administration (FDA) indicates that the number of approved point-of-care devices has increased by over 50% in the last five years.

Companies such as Siemens Healthineers and Ge Healthcare are at the forefront of developing these advanced technologies, which offer capabilities like real-time data analytics and connectivity, further supporting the shift towards decentralized healthcare. This trend aligns with the demand for timely and accurate health assessments, particularly in rural and underserved areas.

### **Rising Demand for Home Healthcare Services**

The growing preference for home healthcare services is significantly impacting the US Point of Care Technology Market industry. Following the COVID-19 pandemic, there has been an increased focus on remote patient monitoring and at-home treatment options. The US Department of Health and Human Services reported a 40% increase in the adoption of home health care services in 2020, highlighting the changing landscape of healthcare delivery.

This shift reflects a reduction in hospital visits and a preference for personalized care within the comfort of one's home. Companies like Philips Healthcare are pivoting towards creating point-of-care solutions tailored for home use, such as telehealth platforms and mobile health applications, which are driving market expansion.

## **US Point of Care Technology Market Segment Insights**

### **Point of Care Technology Market Product Type Insights**

The US [Point of Care Technology](../../../reports/point-of-care-technology-market-1164) Market exhibits significant diversity across its Product Type segment, reflecting the dynamic environment of healthcare technology. This market includes critical areas such as Blood Glucose Monitoring Devices, Diagnostic Imaging Devices, Cardiac Monitoring Devices, and Infectious Disease Testing Devices, each playing an essential role in enhancing patient care and improving health outcomes. Blood Glucose Monitoring Devices are vital for managing diabetes, allowing for real-time monitoring, which is crucial in preventing complications associated with the condition.

This segment is dominated by a growing population of diabetic patients in the US, necessitating easy access to testing solutions that improve self-management of their health. On the other hand, Diagnostic Imaging Devices encompass technologies like ultrasound, MRI, and X-ray machines, which are pivotal for accurate diagnostics. The rise in preventive healthcare measures in the US has heightened the demand for such devices, driving innovation and making them indispensable for early disease detection and management.

Cardiac Monitoring Devices are also prominent within the market, addressing the increasing prevalence of cardiovascular diseases in the nation. With advances in portable and wearable technology, these devices offer continuous monitoring, providing clinicians with real-time data that can lead to timely interventions and improved patient outcomes. Additionally, Infectious Disease Testing Devices have gained traction, especially in light of recent public health challenges.

Rapid testing technologies have shown their importance in controlling outbreaks and ensuring swift diagnostic capabilities, thereby playing a significant role in public health preparedness. These various segments are interconnected; the advancement in one often propels innovation in another. As the US healthcare landscape continues to evolve, particularly with a shift towards patient-centric care, the importance of each Product Type within the Point of Care Technology Market becomes increasingly clear, shaping the future innovations and policies aimed at enhancing healthcare delivery in the country.

Overall, the US Point of Care Technology Market segmentation reflects a convergence of technology, healthcare needs, and consumer demand, showing a strong trajectory towards more accessible, efficient, and patient-focused solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Point of Care Technology Market End User Insights**

The US Point of Care Technology Market is significantly influenced by its End User landscape, which encompasses various settings such as Hospitals, Clinics, Home Care Settings, and Ambulatory Surgical Centers. Hospitals typically account for the majority holding in point of care technology as they require rapid diagnostic capabilities to enhance patient outcomes. Clinics also play a critical role by adopting user-friendly devices that facilitate immediate patient care and reduce the burden on larger healthcare facilities.

Home Care Settings have gained traction due to the growing trend of at-home healthcare services, providing patients with convenience and improved management of chronic conditions. Ambulatory Surgical Centers are increasingly incorporating point of care technologies to enhance procedural efficiency and patient safety, representing a shift towards outpatient care. Overall, the US Point of Care Technology Market continues to exhibit diverse needs across these segments, driving innovation and improving healthcare delivery through tailored solutions. Market growth in these sectors is propelled by technological advancements, an increasing prevalence of chronic diseases, and an emphasis on patient-centric care.

However, challenges such as regulatory hurdles and interoperability issues may impact the seamless integration of these technologies across platforms.

### **Point of Care Technology Market Technology Insights**

The US Point of Care Technology Market focuses heavily on various technologies that enhance rapid diagnostics and patient care delivery. Among these, Microfluidics has gained traction due to its ability to handle small fluid volumes, resulting in faster and more efficient testing processes. Lateral Flow Technology is prevalent as it provides simple and effective testing solutions across a variety of settings, particularly for infectious diseases. Biosensors play a critical role in real-time monitoring and offer significant advantages in diabetes management and other chronic conditions.

Molecular Diagnostics is increasingly important for its precision and early disease detection capabilities, especially for genetic disorders. These technologies collectively drive the US Point of Care Technology Market, addressing the urgent need for timely medical responses and improving patient outcomes. The increasing demand for decentralized healthcare solutions further fuels market growth, while regulatory challenges and technological advancements shape the future landscape. Overall, advancements in these areas are expected to propel innovation, enhance accessibility, and transform the patient care experience in the US.

### **Point of Care Technology Market Application Insights**

The US Point of Care Technology Market, particularly within the Application segment, is evolving to address diverse healthcare needs, reflecting significant advancements. Diabetes Management plays a crucial role as it enables real-time monitoring of blood glucose levels, facilitating timely interventions and reducing long-term complications associated with the disease. Infectious Diseases is also a vital area, as rapid testing technologies enhance the ability to respond promptly to epidemics, significantly impacting public health outcomes.

Cardiology applications become increasingly important due to the rising prevalence of cardiovascular diseases, driving demand for tools that assist in immediate diagnosis and management. Additionally, Oncology applications are crucial in providing timely diagnostic capabilities, leading to earlier treatment initiation which is critical for successful patient outcomes. Overall, these applications exhibit strong growth potential, fueled by increasing healthcare expenditure, a heightened focus on patient-centric care, and technological innovations aimed at improving diagnostic accuracy and efficiency across the healthcare spectrum in the US.

## **US Point of Care Technology Market Key Players and Competitive Insights**

The competitive insights of the US Point of Care Technology Market reveal a dynamic landscape characterized by rapid advancements, innovation, and a robust increase in demand for healthcare solutions that provide immediate results. This market has seen significant growth due to various factors, including the rising prevalence of chronic diseases, an aging population, and a heightened focus on patient-centered care. Companies operating in this sector are constantly striving to enhance their offerings by integrating cutting-edge technologies, expanding product portfolios, and forming strategic partnerships.

The focus on accessibility and efficiency in healthcare is driving competition as stakeholders aim to differentiate themselves through superior service delivery and improved patient outcomes, while regulatory considerations and reimbursement models also shape the operational landscape. Siemens Healthineers has established a significant presence in the US Point of Care Technology Market, bringing forth an array of products that cater to the needs of healthcare professionals and patients alike. The company's strengths lie in its advanced diagnostic capabilities and commitment to innovation, which positions it favorably in a competitive environment.

Siemens Healthineers leverages its robust research and development framework to create reliable and efficient point of care solutions that enhance clinical decision-making. The company's integrated approach not only spans diagnostic imaging but also includes laboratory diagnostics and digital health solutions, making it a comprehensive player in the market. With a strong emphasis on user-friendly interfaces and connectivity, Siemens Healthineers effectively addresses the increasing demand for rapid testing and real-time results.

Roche Diagnostics, a key player in the US Point of Care Technology Market, is renowned for its extensive product offerings and innovative solutions tailored to meet the diverse needs of healthcare providers. The company focuses on developing cutting-edge diagnostic tools that enhance point of care testing, with significant emphasis on areas such as molecular diagnostics, blood glucose monitoring, and cardiac markers. Roche Diagnostics boasts a strong market presence, bolstered by strategic mergers and acquisitions that have expanded its capabilities and resources. The company's strengths lie in its comprehensive range of diagnostic solutions that improve patient management and treatment outcomes.

Additionally, Roche Diagnostics emphasizes partnerships with healthcare facilities and integration with electronic health records, streamlining processes and enhancing accessibility in the US healthcare landscape. Through continual advancements and a commitment to quality, Roche Diagnostics maintains a competitive advantage in the rapidly evolving point of care technology sector.

### **Key Companies in the US Point of Care Technology Market Include**

## **US Point of Care Technology Market Industry Developments**

The US Point of Care Technology Market has seen significant developments recently, especially with advancements in diagnostic tools and technologies that have gained traction due to an increased emphasis on timely and accurate healthcare delivery. Companies such as Siemens Healthineers and Roche Diagnostics are continuously innovating, resulting in enhanced product offerings that cater to urgent healthcare needs. During March 2023, Abbott Laboratories launched a new digital platform aimed at improving chronic disease management in point-of-care settings.

Additionally, a noteworthy merger occurred in May 2023, when Becton Dickinson acquired a small diagnostics firm specializing in rapid testing solutions, further solidifying their position in the market. The market has also experienced valuation growth; for instance, the overall market size has increased, reflecting a growing demand for convenient testing options that support home care and telehealth services. Major happenings over the past couple of years include the heightened adoption of rapid testing technologies during the COVID-19 pandemic, which has left a lasting impact on how point-of-care solutions are perceived by healthcare providers and patients alike.

Emerging trends indicate a focus on integrating digital health technologies into point-of-care testing.

## **US Point of Care Technology Market Segmentation Insights**

### **Point of Care Technology Market Product Type Outlook**

### **Point of Care Technology Market End User Outlook**

### **Point of Care Technology Market Technology Outlook**

### **Point of Care Technology Market Application Outlook**

## Market Drivers

### Growing Aging Population

The demographic shift towards an aging population is significantly impacting the point-of-care-technology market. As the US population ages, there is an increasing prevalence of chronic diseases that require ongoing monitoring and management. This trend is underscored by projections indicating that by 2030, nearly 20% of the US population will be over 65 years old. Consequently, the demand for point-of-care technologies that facilitate regular health assessments and chronic disease management is expected to rise. Healthcare providers are likely to adopt these technologies to improve care delivery and enhance the quality of life for elderly patients, thereby driving growth in the point-of-care-technology market.

### Rising Demand for Rapid Diagnostics

The point of-care-technology market is experiencing a notable surge in demand for rapid diagnostic solutions. This trend is largely driven by the need for timely and accurate patient assessments, particularly in emergency and primary care settings. According to recent data, the market for point-of-care diagnostics is projected to reach approximately $30 billion by 2026, reflecting a compound annual growth rate (CAGR) of around 10%. This growth is indicative of healthcare providers' increasing reliance on point-of-care technologies to facilitate immediate decision-making and improve patient outcomes. As healthcare systems strive to enhance efficiency and reduce wait times, the adoption of rapid diagnostic tools is likely to expand, thereby propelling the point of-care-technology market forward.

### Integration of Artificial Intelligence

The incorporation of artificial intelligence (AI) into point-of-care technologies is emerging as a transformative driver within the market. AI algorithms are being utilized to enhance diagnostic accuracy and streamline workflows, thereby improving overall efficiency in healthcare delivery. Current estimates suggest that the AI healthcare market could reach $36 billion by 2025, with point-of-care applications playing a pivotal role. By leveraging AI, healthcare providers can analyze patient data more effectively, leading to personalized treatment plans and better patient outcomes. This technological evolution is likely to propel the point-of-care-technology market as stakeholders seek innovative solutions to meet the demands of modern healthcare.

### Increased Focus on Preventive Healthcare

The point of-care-technology market is benefiting from a growing emphasis on preventive healthcare measures. As healthcare systems in the US prioritize early detection and management of diseases, point-of-care technologies are becoming essential tools for screening and monitoring health conditions. This shift is reflected in the increasing investments in point-of-care testing solutions, which are projected to account for over 40% of the total diagnostic market by 2025. The ability to conduct tests at the point of care not only enhances patient convenience but also supports healthcare providers in making informed decisions quickly, thereby fostering a proactive approach to health management.

### Advancements in Mobile Health Technologies

The integration of mobile health technologies is significantly influencing the point of-care-technology market. With the proliferation of smartphones and portable devices, healthcare professionals are increasingly utilizing mobile applications for diagnostics and patient monitoring. This shift is supported by data indicating that the mobile health market is expected to exceed $100 billion by 2025. Such advancements enable healthcare providers to deliver care more efficiently, particularly in remote or underserved areas. The convenience and accessibility offered by mobile health solutions are likely to enhance patient engagement and adherence to treatment protocols, thereby driving further growth in the point-of-care-technology market.

## Future Outlook

The [Point of Care Technology Market](https://www.marketresearchfuture.com/reports/point-of-care-technology-market-1164) is projected to grow at a 6.63% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for rapid diagnostics, and a shift towards decentralized healthcare.

**New opportunities:**

- Development of portable diagnostic devices for remote patient monitoring.
- 
- Integration of AI-driven analytics in point-of-care testing.
- Expansion of telehealth services incorporating point-of-care solutions.

By 2035, the market is expected to achieve substantial growth, enhancing healthcare delivery and accessibility.

## Segment Insights

### By Product Type: Blood Glucose Monitoring Devices (Largest) vs. Cardiac Monitoring Devices (Fastest-Growing)

In the US point of-care-technology market, Blood Glucose Monitoring Devices dominate the landscape, holding the largest market share among various product types. Following closely are Diagnostic Imaging Devices, while Cardiac Monitoring Devices and Infectious Disease Testing Devices are also significant but have relatively smaller shares. The distribution demonstrates a clear preference for devices that provide immediate and accurate health information, driving adoption across various healthcare settings.

Growth trends indicate a robust demand for Cardiac Monitoring Devices, attributed to the rising incidence of cardiovascular diseases and an increasing emphasis on remote patient monitoring solutions. Market drivers include technological advancements, increased awareness of preventive healthcare, and soaring demand for rapid diagnostics in point-of-care settings. These currents shape the competitive landscape, positioning specific product types as essential components in modern healthcare delivery.

Blood Glucose Monitoring Devices (Dominant) vs. Cardiac Monitoring Devices (Emerging)

Blood Glucose Monitoring Devices hold a dominant position in the US point of-care-technology market, being essential for diabetes management. They offer users convenient, accurate readings that empower individuals to make timely health decisions. Enhanced features like smartphone connectivity and real-time data sharing further bolster their relevance in clinical and home settings. On the other hand, Cardiac Monitoring Devices are emerging as a pivotal area of growth, propelled by the increasing prevalence of heart diseases and a growing preference for telehealth solutions. Innovations in wearable technology and remote monitoring are enabling more personalized and effective management of cardiac conditions, thus amplifying their appeal and market penetration.

### By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the US point of-care-technology market, hospitals hold the largest share due to their extensive infrastructure and demand for immediate healthcare solutions. Their reliance on innovative technology to improve patient outcomes helps them secure significant market presence. Meanwhile, clinics and ambulatory surgical centers are also prominent but lag behind hospitals in overall market share allocation. 

The fastest-growing segment is home care settings, which are increasingly favored as healthcare moves towards decentralized delivery models. This shift is fueled by rising patient preferences for receiving care at home and advancements in portable point-of-care technologies that simplify remote monitoring and diagnostics. These trends indicate a transformative shift in how care is delivered across various healthcare settings.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Hospitals represent the dominant force in the US point of-care-technology market, characterized by their investment in advanced medical technologies and expansive facilities that cater to a high volume of patients. Their infrastructure supports an array of diagnostic and monitoring tools that enhance operational efficiency and patient care. In contrast, home care settings are emerging as a pivotal player, driven by advancements in technology that allow for high-quality remote care. This segment is marked by innovative solutions tailored for home use, addressing chronic diseases and enhancing patient comfort. The increasing trend towards personalized healthcare is propelling home care technologies into a vital position within the market.

### By Technology: Microfluidics (Largest) vs. Lateral Flow Technology (Fastest-Growing)

The US point of-care-technology market exhibits a diverse array of segment values, with Microfluidics leading the market owing to its advanced capabilities in sample handling and analysis. This technology accounts for a significant portion of the market share, driven by increasing demand for precise diagnostics in various medical applications. Following closely is Lateral Flow Technology, known for its simplicity and rapid results, which is rapidly gaining traction among users seeking efficient and reliable testing methods.

Growth trends in the US point of-care-technology market reveal a robust expansion trajectory, particularly for Lateral Flow Technology, which is considered the fastest-growing segment due to its application in home testing and emergency diagnostics. The rising prevalence of chronic diseases and the need for immediate diagnostic results are key drivers for this market's growth. Moreover, advancements in biosensors and molecular diagnostics are further contributing to the overall dynamism of this segment, fostering innovation and enhancing patient care.

Technology: Microfluidics (Dominant) vs. Lateral Flow Technology (Emerging)

Microfluidics stands out as the dominant force within the US point of-care-technology market, known for its precision and ability to integrate multiple processes on a single chip. This segment is characterized by its capacity for miniaturization, which leads to faster and more accurate diagnostic results. In contrast, Lateral Flow Technology is emerging as a significant competitor, primarily recognized for its user-friendly design and rapid testing capabilities. The effectiveness of Lateral Flow devices in various applications, from pregnancy tests to infectious disease detection, illustrates their growing importance. As healthcare trends shift towards point-of-care testing, both segments are poised to play crucial roles in shaping the future of diagnostics.

### By Application: Diabetes Management (Largest) vs. Infectious Diseases (Fastest-Growing)

The market share distribution within the application segment of point-of-care technology showcases Diabetes Management as the dominant player, capturing a significant portion of the market due to its critical role in monitoring and managing chronic conditions. In contrast, Infectious Diseases is emerging robustly, driven by increasing incidences of infectious outbreaks and the necessity for rapid diagnostic tools, positioning it as a rapidly growing area of interest for healthcare stakeholders.

The growth trends in this segment are shaped by technological advancements and a rising demand for more effective and efficient healthcare solutions. Innovations in mobile health technologies and point-of-care testing are particularly driving the uptake of solutions in the Infectious Diseases segment. Additionally, regulatory support for rapid diagnostics is further propelling market growth, indicating a shift towards more proactive healthcare management strategies.

Diabetes Management (Dominant) vs. Infectious Diseases (Emerging)

Diabetes Management in the US point-of-care-technology market is characterized by its widespread adoption of devices such as glucometers and continuous glucose monitoring systems, recognized for their essential role in managing diabetes effectively. This segment enjoys robust support from healthcare providers and patients alike, playing a critical role in daily health management. On the other hand, the Infectious Diseases segment, though currently emerging, is witnessing rapid growth driven by the need for timely diagnostics in response to ongoing public health challenges. This area is characterized by a surge in innovative testing solutions that provide quick results, enhancing patient outcomes and improving management of outbreaks. Together, these segments reflect the dynamic nature of healthcare needs and innovations in diagnostic technologies.

## Competitive Benchmarking

The point-of-care technology market is characterized by a dynamic competitive landscape, driven by the increasing demand for rapid diagnostic solutions and the ongoing shift towards decentralized healthcare. Key players such as Abbott Laboratories (US), Roche Diagnostics (CH), and Thermo Fisher Scientific (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Abbott Laboratories (US) focuses on expanding its product portfolio through continuous innovation, particularly in the area of rapid testing solutions, which appears to resonate well with healthcare providers seeking efficiency. Meanwhile, Roche Diagnostics (CH) emphasizes its commitment to integrating advanced digital solutions into its offerings, thereby enhancing the user experience and operational efficiency. Thermo Fisher Scientific (US) adopts a strategy centered on mergers and acquisitions, aiming to bolster its capabilities in point-of-care diagnostics, which collectively shapes a competitive environment that is increasingly reliant on technological advancements and strategic collaborations.The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure of the market is moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Abbott Laboratories (US) and Roche Diagnostics (CH) suggests a trend towards consolidation, as these firms seek to leverage their strengths to capture a larger share of the growing market.
In October Abbott Laboratories (US) announced the launch of a new rapid diagnostic test aimed at detecting infectious diseases, which is expected to significantly enhance its market presence. This strategic move not only aligns with the growing demand for quick diagnostic solutions but also positions Abbott as a leader in innovation within the sector. Similarly, in September 2025, Roche Diagnostics (CH) unveiled a new digital platform designed to streamline the integration of point-of-care testing into clinical workflows. This initiative underscores Roche's commitment to enhancing the efficiency of healthcare delivery, potentially setting a new standard for operational excellence in the industry.
In August Thermo Fisher Scientific (US) completed the acquisition of a leading point-of-care diagnostics company, which is anticipated to expand its product offerings and enhance its competitive edge. This acquisition reflects a broader trend in the market where companies are increasingly looking to consolidate their capabilities to better serve the evolving needs of healthcare providers. Such strategic actions are indicative of a market that is rapidly adapting to technological advancements and shifting consumer expectations.
As of November current competitive trends in the point-of-care technology market include a pronounced focus on digitalization, sustainability, and the integration of artificial intelligence (AI) into diagnostic processes. Strategic alliances are becoming increasingly pivotal, as companies recognize the value of collaboration in driving innovation and enhancing product offerings. Looking ahead, it is likely that competitive differentiation will evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition suggests that companies that prioritize these elements will be better positioned to thrive in an increasingly competitive landscape.

## Recent News & Developments

The US Point of Care Technology Market has seen significant developments recently, especially with advancements in diagnostic tools and technologies that have gained traction due to an increased emphasis on timely and accurate healthcare delivery. Companies such as Siemens Healthineers and Roche Diagnostics are continuously innovating, resulting in enhanced product offerings that cater to urgent healthcare needs. During March 2023, Abbott Laboratories launched a new digital platform aimed at improving chronic disease management in point-of-care settings.

Additionally, a noteworthy merger occurred in May 2023, when Becton Dickinson acquired a small diagnostics firm specializing in rapid testing solutions, further solidifying their position in the market. The market has also experienced valuation growth; for instance, the overall market size has increased, reflecting a growing demand for convenient testing options that support home care and telehealth services. Major happenings over the past couple of years include the heightened adoption of rapid testing technologies during the COVID-19 pandemic, which has left a lasting impact on how point-of-care solutions are perceived by healthcare providers and patients alike.

Emerging trends indicate a focus on integrating digital health technologies into point-of-care testing.

## Report Scope

| MARKET SIZE 2024 | 3674.16(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 3917.76(USD Million) |
| MARKET SIZE 2035 | 7445.76(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.63% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), Becton Dickinson and Company (US), Danaher Corporation (US), Cepheid (US), Ortho Clinical Diagnostics (US), Hologic Inc. (US) |
| Segments Covered | Product Type, End User, Technology, Application |
| Key Market Opportunities | Integration of artificial intelligence in point-of-care-technology enhances diagnostic accuracy and patient outcomes. |
| Key Market Dynamics | Technological advancements drive rapid adoption of point-of-care technology, enhancing diagnostic capabilities and patient outcomes. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US point-of-care technology market?**
A: The market valuation was $3674.16 Million in 2024.

**Q: What is the projected market valuation for the US point-of-care technology market by 2035?**
A: The projected valuation for 2035 is $7445.76 Million.

**Q: What is the expected CAGR for the US point-of-care technology market during the forecast period 2025 - 2035?**
A: The expected CAGR is 6.63% during the forecast period.

**Q: Which product type segment had the highest valuation in 2024?**
A: The Infectious Disease Testing Devices segment had a valuation of $1274.16 Million in 2024.

**Q: What are the key players in the US point-of-care technology market?**
A: Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific.

**Q: Which end user segment is projected to grow the most by 2035?**
A: The Ambulatory Surgical Centers segment is projected to grow significantly, with a valuation of $2445.76 Million by 2035.

**Q: What technology segment is expected to see substantial growth by 2035?**
A: The Lateral Flow Technology segment is expected to reach $2500.00 Million by 2035.

**Q: How did the Blood Glucose Monitoring Devices segment perform in 2024?**
A: The Blood Glucose Monitoring Devices segment had a valuation of $800.00 Million in 2024.

**Q: What application segment is anticipated to have a high valuation by 2035?**
A: The Oncology application segment is anticipated to reach $2545.76 Million by 2035.

**Q: What is the valuation range for Cardiac Monitoring Devices in 2024?**
A: The valuation range for Cardiac Monitoring Devices was $700.00 Million to $1400.00 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-point-of-care-technology-market-15482*